Future Direction of Stem Cells in Cardiovascular Disease

Continuing Medical Education

Future Direction of Stem Cells - Symposium

Registration onsite will be accepted
and we look forward to seeing you
in New Orleans.

Future Direction of Stem Cells
in Cardiovascular Disease

Presented by
Texas Heart Institute
as a satellite to
American Heart Association
Scientific Sessions.

Friday, November 7, 2008

3:00 p.m. — 6:15 p.m.

Hilton New Orleans Riverside
(Lower-level conference center)
New Orleans, Louisiana

Overview

Almost six million Americans have congestive heart failure, a progressive form of cardiovascular disease that inhibits the heart from pumping blood throughout the body, and 550,000 new cases are diagnosed each year. About half of these patients die within five years after receiving a diagnosis of severe heart failure.

The study of adult stem cells and their role in treating cardiovascular disease is quickly becoming an acceptable mode of treatment. The challenge remains to identify the very best types of stem cells, refine our delivery techniques, and establish the most effective doses of stem cells.

Target Audience
Cardiologists desiring to further their knowledge of how stem cells play a role in heart failure, acute myocardial infarction, and peripheral vascular disease will find the discussions timely and relevant to their practice in providing improved patient care.

The goal of this symposium is to educate physicians on the clinical application of stem cells in cardiovascular disease.

Learning Objectives
At the conclusion of this symposium, participants should be able to–

Summarize recent scientific advances related to the use of stem cells in treating heart failure, acute myocardial infarction and peripheral vascular disease.
Describe the mechanism of action of cell therapy in the treatment of cardiovascular disease.
Discuss the use of stem cells in the regeneration of damaged heart tissues.

Program

Friday November 7, 2008 - 3:00 p.m. to 6:15 p.m.

Stem Cells in Cardiovascular Disease: Where Are We Today?
Cell Therapy of Cardiovascular Disease: What Is the Mechanism of Action?
Adult Stem Cells for Cardiac Repair
Cell Therapy of Cardiovascular Disease: Clinical Determinants of Efficacy
And a live broadcast from Texas Heart Institute

Program Faculty

James T. Willerson, MD - Program Director

Stefanie Dimmeler, PhD

Edward T. Yeh, MD

Emerson C. Perin, MD, PhD

Douglas Losordo, MD

Joshua Hare, MD

Doris Taylor, PhD

Andreas Zeiher, PhD

Accreditation

Texas Heart Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Texas Heart Institute designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

An evaluation form will provide each participant the opportunity to review the speakers and their presentations, to identify educational needs, and to comment on any perceived commercial or promotional bias in the presentation.

Meeting Site

The symposium will be held at the Hilton New Orleans Riverside located across the street from the Ernest N. Morial Convention Center. The hotel's address is 2 Poydras Street, New Orleans, Louisiana.

The conference center is located on the lower level of the hotel.

Cancellation Policy
All symposium cancellations must be received in writing by October 27, 2008. The Texas Heart Institute reserves the right to cancel the symposium if enrollment is deemed insufficient.

Registration

Online registration is now closed.

Registration onsite will be accepted and we look forward to seeing you
in New Orleans.

We subscribe to HONcode.
Verify here.

Please contact our Webmaster with questions or comments.
Terms of Use and Privacy Policy
© Copyright 1996-2008 Texas Heart Institute. All rights reserved.
Texas Heart Institute, Texas Heart, Texas Heart Institute Journal, THI, Heart Owner's, Leading With the Heart and Heart of Discovery are members of the
family of trademarks of the Texas Heart Institute.

USNews and World Report America's Best Hospitals - 2008